On October 20, 2015, a motion for authority to obtain debtor-in-possession financing was filed in the bankruptcy case of Cardiac Science Corporation and its affiliates.
The filing was assigned docket number 29 and is described on the court’s official docket as follows:
Chapter 11 First Day Motion Motion for Interim and Final Orders Authorizing (A) Secured Post-Petition Financing on a Super Priority Basis Pursuant to 11 U.S.C. §§ 363, 364, and 507(b), (B) Use of Cash Collateral Pursuant to 11 U.S.C. § 363, (C) the Grant of Adequate Protection Pursuant to §§ 363 and 364 and (D) Modification of the Automatic Stay filed by Daryl L. Diesing on behalf of Cardiac Science Corporation. (Attachments: # 1 Exhibit (s) A # 2 Exhibit (s) B – Proposed Order) (Diesing, Daryl) (Entered: 10/20/2015)
Cardiac Science Corporation filed for bankruptcy protection, or had an involuntary bankruptcy petition filed against it, on October 20, 2015. The bankruptcy case is pending before the United States Bankruptcy Court for the Western District of Wisconsin. The case number for the lead bankruptcy case is 15-13766. The bankruptcy case is currently assigned to United States Bankruptcy Judge Robert Martin . The law firm of Whyte Hirschboeck Dudek S.C. is acting as lead bankruptcy counsel to Cardiac Science Corporation in the bankruptcy case.